These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 5924958

  • 1. Chemotherapy of leukemia L1210 in mice with 1-beta-D-arabinofuranosylcytosine hydrochloride. II. Effectiveness against intracerebrally and subcutaneously inoculated leukemic cells.
    Kline I, Venditti JM, Tyrer DD, Mantel N, Goldin A.
    Cancer Res; 1966 Sep; 26(9):1930-7. PubMed ID: 5924958
    [No Abstract] [Full Text] [Related]

  • 2. Chemotherapy of leukemia L1210 in mice with 1-beta-d-arabinofuranosylcytosine hydrochloride. I. Influence of treatment schedules.
    Kline I, Venditti JM, Tyrer DD, Goldin A.
    Cancer Res; 1966 May; 26(5):853-9. PubMed ID: 5936445
    [No Abstract] [Full Text] [Related]

  • 3. Enhancement by tetrahydrouridine of 1-beta-D-arabinofuranosylcytosine (cytarabine) oral activity in L1210 leukemic mice.
    Neil GL, Moxley TE, Manak RC.
    Cancer Res; 1970 Aug; 30(8):2166-72. PubMed ID: 4990003
    [No Abstract] [Full Text] [Related]

  • 4. Separate and sequential chemotherapy of mouse leukemia L1210 with 1-beta-D-arabinofuranosylcytosine hydrochloride and 1,3-bis(2-chloroethyl)-1-nitrosourea.
    Tyrer DD, Kline I, Venditti JM, Goldin A.
    Cancer Res; 1967 May; 27(5):873-9. PubMed ID: 6025252
    [No Abstract] [Full Text] [Related]

  • 5. Antitumor effect and mode of action of 1-beta-D-arabinofuranosylcytosine 5'-phosphate in leukemia L1210.
    Schrecker AW, Goldin A.
    Cancer Res; 1968 Apr; 28(4):802-3. PubMed ID: 5649067
    [No Abstract] [Full Text] [Related]

  • 6. Synthesis and structure-activity studies in vivo of liposomal phospholipid-N4-palmitoyl- and N4-hexadecyl-1-beta-D-arabinofuranosylcytosine conjugates.
    Schott H, Schwendener RA.
    Anticancer Drug Des; 1996 Sep; 11(6):451-62. PubMed ID: 8836110
    [Abstract] [Full Text] [Related]

  • 7. Sedimentation of DNA from L1210 cells after treatment with 4'-demethylepipodophyllotoxin-9-(4,6-O-2-thenylidene-beta-D-glucopyranoside) or 1-beta-D-arabinofuranosylcytosine or both drugs.
    Roberts D, Hilliard S, Peck C.
    Cancer Res; 1980 Nov; 40(11):4225-31. PubMed ID: 7471063
    [No Abstract] [Full Text] [Related]

  • 8. Antitumor effect of 1-beta-D-arabinofuranosylcytosine 5'-adamantoate (NSC 117614) in L1210 leukemic mice.
    Neil GL, Wiley PF, Manak RC, Moxley TE.
    Cancer Res; 1970 Apr; 30(4):1047-54. PubMed ID: 5504347
    [No Abstract] [Full Text] [Related]

  • 9. Antileukemic activity of 1-beta-D-arabinofuranosyl-2-amino-1,4(2H)-4-iminopyrimidine, a new depot form of 1-beta-D-arabinofuranosylcytosine.
    Khwaja TA, Kigwana LJ, Mian AM.
    Cancer Res; 1979 Aug; 39(8):3129-33. PubMed ID: 455296
    [No Abstract] [Full Text] [Related]

  • 10. Role of liposome type and route of administration in the antitumor activity of liposome-entrapped 1-beta-D-arabinofuranosylcytosine against mouse L1210 leukemia.
    Rustum YM, Dave C, Mayhew E, Papahadjopoulos D.
    Cancer Res; 1979 Apr; 39(4):1390-5. PubMed ID: 421223
    [No Abstract] [Full Text] [Related]

  • 11. Combination effects of Ara-C and 5-fluorodeoxyuridine against leukemia cells in vitro and in mice.
    Rauko P, Bauer W, Horvath Z, Höchtl T, Saiko P, Karl D, Schott H, Fritzer-Szekeres M, Novotny L, Szekeres T.
    Anticancer Res; 2003 Apr; 23(5A):3841-6. PubMed ID: 14666686
    [Abstract] [Full Text] [Related]

  • 12. Antitumor activity of 1-beta-D-arabinofuranosylcytosine conjugated with polyglutamic acid and its derivative.
    Kato Y, Saito M, Fukushima H, Takeda Y, Hara T.
    Cancer Res; 1984 Jan; 44(1):25-30. PubMed ID: 6197162
    [Abstract] [Full Text] [Related]

  • 13. Biochemical and genetic studies of a mutant strain of mouse leukemia L1210 resistant to 1-beta-D-arabinofuranosylcytosine (Cytarabine).
    Bach MK.
    Cancer Res; 1969 May; 29(5):1036-44. PubMed ID: 5781095
    [No Abstract] [Full Text] [Related]

  • 14. Increased activation of 1-beta-D-arabinofuranosylcytosine by hydroxyurea in L1210 cells.
    Walsh CT, Craig RW, Agarwal RP.
    Cancer Res; 1980 Sep; 40(9):3286-92. PubMed ID: 7427943
    [Abstract] [Full Text] [Related]

  • 15. Production of N4-succinyl-1-beta-D-arabinofuranosylcytosine, a novel metabolite of N4-behenoyl-1-beta-D-arabinofuranosylcytosine, in mice and its biological significance.
    Oh-ishi J, Kataoka T, Tsukagoshi S, Sakurai Y, Shibukawa M, Kobayashi H.
    Cancer Res; 1981 Jun; 41(6):2501-6. PubMed ID: 7237444
    [Abstract] [Full Text] [Related]

  • 16. Reduction in the frequency of mutation to resistance to cytarabine in L1210 murine leukemic cells by treatment with quinacrine hydrochloride.
    Bach MK.
    Cancer Res; 1969 Oct; 29(10):1881-5. PubMed ID: 5823955
    [No Abstract] [Full Text] [Related]

  • 17. Basis of observed resistance of L1210 leukemia in mice: methotrexate, 6-thioguanine, 6-methylmercaptopurine riboside, 6-mercaptopurine, 5-fluorouracil, and 1-beta-D-arabinofuranosylcytosine administered in different combinations.
    Kim K, Blechman WJ, Riddle VG, Pardee AB.
    Cancer Res; 1981 Nov; 41(11 Pt 1):4529-34. PubMed ID: 7198006
    [Abstract] [Full Text] [Related]

  • 18. Enhancement of 1-beta-D-arabinofuranosylcytosine accumulation within L1210 cells and increased cytotoxicity following thymidine exposure.
    Grant S, Lehman C, Cadman E.
    Cancer Res; 1980 May; 40(5):1525-31. PubMed ID: 7370990
    [No Abstract] [Full Text] [Related]

  • 19. Combined chronochemotherapy of L1210 leukemic mice using 1-beta-D-arabinofuranosylcytosine, cyclophosphamide, vincristine, methylprednisolone and cis-diamminedichloroplatinum.
    Scheving LE, Burns ER, Halberg F, Pauly JE.
    Chronobiologia; 1980 May; 7(1):33-40. PubMed ID: 7192203
    [Abstract] [Full Text] [Related]

  • 20. Histidinol-mediated improvement in the specificity of 1-beta-D-arabinofuranosylcytosine and 5-fluorouracil in L 1210 leukemia-bearing mice.
    Warrington RC, Muzyka TG, Fang WD.
    Cancer Res; 1984 Jul; 44(7):2929-35. PubMed ID: 6722819
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.